IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Other Current Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Other Current Liabilities
kr8.4m
CAGR 3-Years
30%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Other Current Liabilities
kr26.6m
CAGR 3-Years
44%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Other Current Liabilities
kr114.7m
CAGR 3-Years
67%
CAGR 5-Years
59%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Other Current Liabilities
kr120.3m
CAGR 3-Years
56%
CAGR 5-Years
80%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Other Current Liabilities
kr3.3m
CAGR 3-Years
-59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Other Current Liabilities
kr10.8m
CAGR 3-Years
112%
CAGR 5-Years
73%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Other Current Liabilities?
Other Current Liabilities
8.4m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Other Current Liabilities amounts to 8.4m SEK.

What is IRLAB Therapeutics AB's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
19%

Over the last year, the Other Current Liabilities growth was 58%. The average annual Other Current Liabilities growth rates for IRLAB Therapeutics AB have been 30% over the past three years , 19% over the past five years .

Back to Top